{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:22:47Z","timestamp":1777004567207,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T00:00:00Z","timestamp":1489708800000},"content-version":"vor","delay-in-days":44,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.vaccine.2017.01.018","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T14:01:05Z","timestamp":1485352865000},"page":"1104-1109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Improving the selection and development of influenza vaccine viruses \u2013 Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18\u201320 November 2015"],"prefix":"10.1016","volume":"35","author":[{"given":"Alan","family":"Hampson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben O.","family":"Donis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirve","family":"Siddhivinayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Jernigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takato","family":"Odagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Webby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thedi","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.01.018_b0005","doi-asserted-by":"crossref","unstructured":"Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A, Horvath JK et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014\/15. Euro Surveill. 2016;21(7):1\u201317 <http:\/\/www.eurosurveillance.org\/images\/dynamic\/EE\/V21N07\/art21385.pdf> [accessed 26 July 2016].","DOI":"10.2807\/1560-7917.ES.2016.21.7.30139"},{"key":"10.1016\/j.vaccine.2017.01.018_b0010","doi-asserted-by":"crossref","unstructured":"WHO Writing Group. Improving influenza vaccine virus selection. Report of a WHO informal consultation. WHO headquarters, Geneva, Switzerland, 14\u201316 June 2010. Influenza and Other Respiratory Viruses. 2012;6(2):142\u201352. <http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1750-2659.2011.00277.x\/abstract> [accessed 26 May 2014].","DOI":"10.1111\/j.1750-2659.2011.00277.x"},{"key":"10.1016\/j.vaccine.2017.01.018_b0015","doi-asserted-by":"crossref","unstructured":"WHO Writing Group. Strengthening the influenza vaccine virus selection and development process. Outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection. Centre International de Conf\u00e9rences (CICG), Geneva, Switzerland, 7\u20139 December 2011. Vaccine. 2013;31(32):3209\u201321. <http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0264410X13006373>, [accessed 26 May 2014].","DOI":"10.1016\/j.vaccine.2013.05.049"},{"key":"10.1016\/j.vaccine.2017.01.018_b0020","unstructured":"WHO Writing Group. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1\u20133 April 2014. Vaccine. 2015;33(36):4368\u201382. <http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0264410X15009056>, [accessed 28 January 2016]."},{"key":"10.1016\/j.vaccine.2017.01.018_b0025","unstructured":"WHO Expert Group meeting on seasonal influenza vaccine composition for tropics and subtropics. Meeting report. Geneva, Switzerland 23\u201324 April 2015. Geneva: World Health Organization; 2015 [WHO\/HSE\/PED\/GIP\/EPI\/2015.1; <http:\/\/apps.who.int\/iris\/bitstream\/10665\/183954\/1\/WHO_HSE_PED_GIP_EPI_2015.1_eng.pdf?ua=1>, accessed 26 January 2016]."},{"key":"10.1016\/j.vaccine.2017.01.018_b0030","unstructured":"Second WHO meeting on seasonal influenza vaccine composition for the tropics and subtropics. Pune, India 8\u201310 July 2015. Geneva: World Health Organization; 2015 [WHO\/HSE\/PED\/GIP\/EPI\/2015.2; <http:\/\/apps.who.int\/iris\/bitstream\/10665\/198067\/1\/WHO_HSE_PED_GIP_EPI_2015.2_eng.pdf>, accessed 26 January 2015]."},{"key":"10.1016\/j.vaccine.2017.01.018_b0035","unstructured":"Seasonal influenza vaccine use in low and middle income countries in the tropics and subtropics. A systematic review. Geneva: World Health Organization; 2015 [<http:\/\/apps.who.int\/iris\/bitstream\/10665\/188785\/1\/9789241565097_eng.pdf>, accessed 26 January 2015]."},{"key":"10.1016\/j.vaccine.2017.01.018_b0040","doi-asserted-by":"crossref","first-page":"21474","DOI":"10.1073\/pnas.1218841110","article-title":"Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin","volume":"109","author":"Lin","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.01.018_b0045","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1128\/JVI.00458-10","article-title":"Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?","volume":"84","author":"Lin","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.01.018_b0050","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J Infect Dis"},{"issue":"7804","key":"10.1016\/j.vaccine.2017.01.018_b0055","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","article-title":"Effect of neuraminidase antibody on Hong Kong influenza","volume":"1","author":"Monto","year":"1973","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2017.01.018_b0060","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.018_b0065","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.vaccine.2015.12.022","article-title":"Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity","volume":"34","author":"Eichelberger","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.018_b0070","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1586\/14760584.2014.966695","article-title":"Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review","volume":"13","author":"Sullivan","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.01.018_b0075","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv417","article-title":"MapMyFlu: visualizing spatio-temporal relationships between related influenza sequences","volume":"43","author":"Nolte","year":"2015","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2017.01.018_b0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature13087","article-title":"A predictive fitness model for influenza","volume":"507","author":"Luksza","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.01.018_b0085","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1093\/bioinformatics\/btv381","article-title":"Nextflu: real-time tracking of seasonal influenza virus evolution in humans","volume":"31","author":"Neher","year":"2015","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.vaccine.2017.01.018_b0090","doi-asserted-by":"crossref","first-page":"16058","DOI":"10.1038\/nmicrobiol.2016.58","article-title":"Selection of antigenically advanced variants of seasonal influenza viruses","volume":"1","author":"Li","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2017.01.018_b0095","doi-asserted-by":"crossref","first-page":"e01914","DOI":"10.7554\/eLife.01914","article-title":"Integrating influenza antigenic dynamics with molecular evolution","volume":"3","author":"Bedford","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2017.01.018_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.12.005","article-title":"Universal influenza vaccines: a realistic option?","author":"de Vries","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.018_b0105","doi-asserted-by":"crossref","first-page":"e88340","DOI":"10.1371\/journal.pone.0088340","article-title":"MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses","volume":"9","author":"Hessel","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.018_b0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/vaccines3010105","article-title":"M2e-based universal influenza A vaccines","volume":"3","author":"Deng","year":"2015","journal-title":"Vaccines"},{"issue":"6254","key":"10.1016\/j.vaccine.2017.01.018_b0115","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2017.01.018_b0120","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17300373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17300373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T23:51:25Z","timestamp":1568764285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17300373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0264410X17300373"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving the selection and development of influenza vaccine viruses \u2013 Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18\u201320 November 2015","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}